Sector: Pharmaceuticals & Biotechnology

Large Cap

Ajanta Pharma Share Price

Ajanta Pharma Ltd.

₹2,975

35.60(1.21%)

Invest in AJANTPHARM with up to 2.86x margin.

Trade with MTF

23rd Feb 2026 | 3:28 PM

NSE : AJANTPHARM

Open Free Demat Account

Ajanta Pharma Performance

Price Movement

₹2975.00

₹2936.70

₹2990.00

↘ Today's Low↗ Today's High

1 Year Performance

₹2975.00

₹2327.30

₹3020.80

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,990.00

Low₹2,936.70

Open at₹2,940.00

Prev Close₹2,939.40

Volumes2.08 L

Avg Price₹2,973.61

Lower Circuit₹2,351.60

Upper Circuit₹3,527.20

Historical Performance

3M High₹3,020.80

3M Low₹2,474.40

1 Yr High₹3,020.80

1 Yr Low₹2,327.30

3 Yr High₹3,485.00

3 Yr Low₹1,131.70

5 Yr High₹3,485.00

5 Yr Low₹1,061.77

Ajanta Pharma Fundamentals

Market Cap

High in industry

37,203.80 Cr.

PE Ratio (TTM)

Above industry Median

36.70

Dividend Yield

Above industry Median

0.90

Net Profit TTM

13.0% incr over last year

1,014.56

Net Profit Growth

13.0% incr over last year

1,014.56

PEG Ratio

High in industry

2.80

ROE

6.2% incr over last year

24.28

Operating Revenue TTM

5,201.63

Operating Revenue Growth

14.8% incr over last year

Book Value

High in industry

8.60

MFI

MFI Overbought

76.85

RSI

RSI is mid-range

68.50

EPS (TTM)

73.56

Debt to Equity

Face Value

Operating Profit Margin Qtr.

26.56

Operating Profit Qtr.

382.24

Net Profit Qtr.

273.77

Operating Revenue Qtr.

1,374.84

PB Ratio

8.60

Ajanta Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	1,206.59	1,220.24	1,208.56	1,013.94	1,101.92
Operating Expense	865.64	930.65	879.16	764.29	765.59
Operating Profit	340.95	289.59	329.40	249.65	336.33
Depreciation	42.38	41.92	40.31	38.76	34.93
Interest	1.87	0.73	0.73	0.67	2.48
Tax	77.42	72.44	74.02	34.72	79.70
Net Profit	245.04	249.53	254.97	193.43	252.45

Ajanta Pharma Technicals

Ajanta Pharma Ltd. EMA & SMA

₹2975.00

35.60 (1.21%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹2954.8

Day EMA10 ₹2929.6

Day EMA12 ₹2919.2

Day EMA20 ₹2882.9

Day EMA26 ₹2860.5

Day EMA50 ₹2792

Day EMA100 ₹2714.9

Day EMA200 ₹2668.8

Ajanta Pharma Support and Resistance

Resistance

First Resistance₹3000.03

Second Resistance₹3021.67

Third Resistance₹3053.33

Support

First Support₹2946.73

Second Support₹2915.07

Third Support₹2893.43

Technical Indicators

Day RSI68.50

Day MFI76.85

Day ADX28.48

Day Commodity Channel Index103.00

William-5.93

Day MACD58.72

Day MACD Signal Line51.94

Day ATR63.79

Day ROC12512.88

Day ROC2110.33

Ajanta Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	66.3	66.3	66.3	66.3	66.2	66.2
FII	9.1	9.3	8.9	8.9	8.5	8
DII	17.1	17	17.5	17.5	17.9	18.6
Public	7.5	7.4	7.4	7.4	7.3	7.2

Ajanta Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	29.3 K	47.03 K	62.29%
Week	55.73 K	82.21 K	67.79%
1 Month	59.85 K	95.7 K	62.54%
6 Month	68.19 K	1.19 L	57.27%

Ajanta Pharma SWOT Analysis

Strengths26

Weakness5

Opportunity7

Threats1

Positive Breakout First Resistance ( LTP > R1)

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 3 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Near 52 Week High

RSI indicating price strength

High Volume, High Gain

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Ajanta Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
10 Nov, 2025	28	INTERIM	10 Nov, 2025	Equity Share
06 Nov, 2024	28	INTERIM	06 Nov, 2024	Equity Share
08 Feb, 2024	26	INTERIM	08 Feb, 2024	Equity Share
04 Aug, 2023	10	INTERIM	04 Aug, 2023	Equity Share
04 Aug, 2023	15	SPECIAL	04 Aug, 2023	Equity Share
11 Nov, 2022	7	INTERIM	14 Nov, 2022	Equity Share
09 Nov, 2021	9.5	INTERIM	10 Nov, 2021	Equity Share
12 Nov, 2020	9.5	INTERIM	13 Nov, 2020	Equity Share
15 Nov, 2019	13	INTERIM	18 Nov, 2019	Equity Share
09 Nov, 2018	9	INTERIM	12 Nov, 2018	Equity Share

Ajanta Pharma Stock Comparison

Financials	Anthem Biosciences Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.	Gland Pharma Ltd.	Laurus Labs Ltd.
Price (₹)	₹696.90	₹1,431.80	₹2,045	₹162	₹1,803	₹1,014.60
% Change	2.20%	-0.42%	1.02%	0.92%	-1.03%	-0.43%
Revenue TTM (₹ Cr)	₹1,996.59	₹8,850.08	₹13,914.08	₹8,871.37	₹6,112.77	₹6,721.63
Net Profit TTM (₹ Cr)	₹484.66	₹869.92	₹1,779.35	₹-163.61	₹847.18	₹843.32
PE TTM	80.70	31.30	47.50	-131.70	35.10	65.10
1 Year Return	22.17	44.17	-12.08	-22.44	18.09	95.04
ROCE	26.88	20.80	13.27	6.40	11.43	11.82

Similar Stocks

ALKEM

Alkem Laboratories Ltd.

₹ 5487.00

+1.76%

BIOCON

Biocon Ltd.

₹ 388.00

+1.05%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6258.50

-0.52%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 905.30

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2033.00

-0.50%

WOCKPHARMA

Wockhardt Ltd.

₹ 1370.00

-0.84%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1148.70

-0.87%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1732.00

+0.44%

IPCALAB

Ipca Laboratories Ltd.

₹ 1469.70

+1.37%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2051.00

+2.53%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8807.00

-0.93%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2635.30

+1.48%

PFIZER

Pfizer Ltd.

₹ 5066.60

+2.74%

ABBOTINDIA

Abbott India Ltd.

₹ 26425.00

+0.49%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4318.50

+1.81%

LUPIN

Lupin Ltd.

₹ 2241.00

+0.97%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1305.10

+1.93%

CIPLA

Cipla Ltd.

₹ 1327.00

-1.05%

FAQ's on AJANTPHARM

What is the current share price of Ajanta Pharma Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Ajanta Pharma Ltd. is ₹ 2975 on the NSE and ₹ 2980 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Ajanta Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Ajanta Pharma Ltd. is approximately ₹ 37203.8 Cr.

What are the PE and PB ratios for Ajanta Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Ajanta Pharma Ltd. is 36.7, and the Price-to-Book (PB) ratio is 8.6.

What is the 52-Week High and Low for Ajanta Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Ajanta Pharma Ltd. shares was ₹ 3020.8, and the lowest price was ₹ 2327.3.

What is the current dividend yield for Ajanta Pharma Ltd.?

As of 6 June 2025, the dividend yield for Ajanta Pharma Ltd. is 0.9%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Ajanta Pharma Ltd.?

Significant shareholdings in Ajanta Pharma Ltd. typically include entities such as:

Promoter
Mutual Funds
FII
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Ajanta Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Ajanta Pharma Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

What is the latest dividend information for Ajanta Pharma Ltd.?

Ajanta Pharma Ltd. last declared a INTERIM dividend of ₹ 28 per share for the financial period ending 2025. The record date was set as 2025-11-10, and the payment was/is scheduled around 2025-11-10. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy